Drag

Torrent Pharmaceuticals Limited

Healthcare TORNTPHARM

4027.10INR
39.90 ( 1.00%)

Last update at

Day Range

4010.204104.10
LowHigh

52 Week Range

2880.98 4104.80
LowHigh

Fundamentals

  • Previous Close 3987.20
  • Market Cap 1362716.66M
  • Volume249,435
  • P/E Ratio 63.48
  • EBITDA 39478.20M
  • Revenue TTM 122480.90M
  • Revenue Per Share TTM 361.87
  • Gross Profit TTM 92701.90M
  • Diluted EPS TTM 63.43

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 26728.10M 23521.10M 18470.00M 12259.10M 15262.60M
Net income 19110.00M 16563.80M 12450.00M 7771.80M 12518.80M
Total Revenue 115160.90M 107278.40M 94640.00M 84188.00M 78862.30M
Gross Profit 87401.90M 80416.30M 67290.00M 58813.30M 56509.30M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 149900.00M 150605.80M 150120.00M 130998.40M 140746.50M
Intangible assets 42630.00M 45828.20M 50890.00M 35460.60M 39840.30M
Other current assets 5240.00M 4841.10M 3030.00M 3120.00M 4510.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -2621.40M 3266.10M 1100.00M -1741.60M -892.60M
Operating Cash 25850.00M 32660.80M 23680.00M 18029.90M 20106.90M
Free Cash Flow 19740.00M 28333.00M 17940.00M 16004.20M 16755.40M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
TORNTPHARM
Torrent Pharmaceuticals Limited
39.90 1.00% 4027.10 1362716.66 63.48
SUNPHARMA
Sun Pharmaceutical Industries Limited
75.40 4.63% 1703.30 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited
336.50 5.65% 6289.00 1752225.28 70.47
CIPLA
Cipla Limited
16.40 1.25% 1328.00 1183505.97 21.74
DRREDDY
Dr. Reddy's Laboratories Limited
53.70 4.54% 1236.20 1004813.29 17.16

Profile

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Torrent Pharmaceuticals Limited

Torrent House, Ahmedabad, India, 380009

Key Executives

Name Title Year Born
Mr. Samir Uttamlal Mehta Exec. Chairman & MD 1964
Mr. Jinesh Shah B.Sc., MBA Exec. Director of Operations & Whole Time Director 1977
Mr. Sudhir Menon CA, CWA Exec. Director of Fin. & CFO 1972
Mr. Chintan Trivedi Company Sec. & Compliance Officer NA
Mr. Abdullah Salam Said Al Abri Chief Customer Service Officer NA
Mr. R. Chandrashekhar Inter CA VP of Procurement 1969
Jaydip Bhatt VP of Human Resource 1953
H. L. Guttikar B.E., MMS VP of Projects 1963
Ashish Hajarnish M.Pharm VP of Works 1968
Hasmukh Patel B.Pharm, M.Pharm. VP of Works 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.